Association of a C/T single-nucleotide polymorphism in the 5′ untranslated region of the CD40-gene with Graves' disease in Japanese

被引:48
作者
Ban, Yoshiyuki
Tozaki, Teruaki
Taniyama, Matsuo
Tomita, Motowo
Ban, Yoshio
机构
[1] Showa Univ, Sch Med, Dept Internal Med 3, Shinagawa Ku, Tokyo 1428666, Japan
[2] Showa Univ, Sch Pharmaceut Sci, Dept Physiol Chem, Tokyo 1428666, Japan
[3] Showa Univ, Fujigaoka Hosp, Div Endocrinol & Metab, Yokohama, Kanagawa 227, Japan
关键词
D O I
10.1089/thy.2006.16.443
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
text: Graves' disease (GD) is caused by an interplay of genetic factors and environmental triggers. Recently, a susceptibility locus for GD was mapped to chromosome 20q11 (GD-2). Furthermore, a novel single nucleotide polymorphism (SNP) in the CD40 gene, which is located in 20q11, was found to be associated and linked with GD in Caucasians and in Koreans. Objectives: To examine a C/T SNP in the 5' untranslated region of the CD40 gene (CD40-E1SNP) for association with autoimmune thyroid diseases (AITDs) in a Japanese dataset. Design, setting, and patients: Case-control association studies were performed using the CD40-E1SNP. We studied 485 Japanese patients with AITD (301 with GD, 184 with Hashimoto's thyroiditis [HT]) and 177 matched Japanese control subjects in association studies. Main outcome: Frequencies of genotypes and alleles of the CD40-E1SNP. Results: The distribution of genotype frequencies differed significantly between patients with GD and controls in a dominant manner (p = 0.039). The CC+CT genotypes of the CD40-E1SNP were associated with the increased risk for GD (p = 0.015, odds ratio [OR] = 1.9). In contrast, no differences in genotype frequencies were observed between HT patients and controls for the CD40-E1SNP. Conclusion: These results suggested that the CD40 gene is involved insusceptibility for GD in the Japanese.
引用
收藏
页码:443 / 446
页数:4
相关论文
共 21 条
  • [1] [Anonymous], 1996, HUM MOL GENET
  • [2] THE CD40 ANTIGEN AND ITS LIGAND
    BANCHEREAU, J
    BAZAN, F
    BLANCHARD, D
    BRIERE, F
    GALIZZI, JP
    VANKOOTEN, C
    LIU, YJ
    ROUSSET, F
    SAELAND, S
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 881 - 922
  • [3] Cigarette smoking and risk of clinically overt thyroid disease - A population-based twin case-control study
    Brix, TH
    Hansen, PS
    Kyvik, KO
    Hegedus, L
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (05) : 661 - 666
  • [4] Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction
    Carayanniotis, G
    Masters, SR
    Noelle, RJ
    [J]. IMMUNOLOGY, 1997, 90 (03) : 421 - 426
  • [5] THE ROLE OF CD40 IN THE REGULATION OF HUMORAL AND CELL-MEDIATED-IMMUNITY
    DURIE, FH
    FOY, TM
    MASTERS, SR
    LAMAN, JD
    NOELLE, RJ
    [J]. IMMUNOLOGY TODAY, 1994, 15 (09): : 406 - 411
  • [6] Immune regulation by CD40 and its ligand GP39
    Foy, TM
    Aruffo, A
    Bajorath, J
    Buhlmann, JE
    Noelle, RJ
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 591 - 617
  • [7] A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians
    Heward, JM
    Simmonds, MJ
    Carr-Smith, J
    Foxall, H
    Franklyn, JA
    Gough, SCL
    [J]. CLINICAL ENDOCRINOLOGY, 2004, 61 (02) : 269 - 272
  • [8] Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994):: National Health and Nutrition Examination Survey (NHANES III)
    Hollowell, JG
    Staehling, NW
    Flanders, WD
    Hannon, WH
    Gunter, EW
    Spencer, CA
    Braverman, LE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) : 489 - 499
  • [9] Role of the CD40 locus in Graves' disease
    Houston, FA
    Wilson, V
    Jennings, CE
    Owen, CJ
    Donaldson, P
    Perros, P
    Pearce, SHS
    [J]. THYROID, 2004, 14 (07) : 506 - 509
  • [10] Epidemiology and estimated population burden of selected autoimmune diseases in the United States
    Jacobson, DL
    Gange, SJ
    Rose, NR
    Graham, NMH
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1997, 84 (03): : 223 - 243